HIMS Shares Tumbled -21%, Opportunity Or Trap?

HIMS: Hims & Hers Health logo
HIMS
Hims & Hers Health

Hims & Hers Health stock has fallen by 21.4% in less than a month, from levels of $64.22 on 6/20/2025 to $50.46 now. Should you buy this dip? Dip buying is a viable strategy for quality stocks that have a history of recovering from dips.

As it turns out, Hims & Hers Health passes basic quality checks and has returned (on average) 87% in one year, and 157% as peak return following sharp dips (>30% in 30 days) historically.

That said, if you seek upside with lower volatility than individual stocks, the Trefis High Quality portfolio presents an alternative – having outperformed the S&P 500 and generated returns exceeding 91% since its inception.

Historical Median Returns Post Dips

Relevant Articles
  1. How to Get Paid to Buy IT at a Steep Discount
  2. Short Apple Stock – Now?
  3. The Next Big Rally in UnitedHealth Stock Could Start Like This
  4. What Can Cause Pfizer Stock To Crash?
  5. Visa Stock Now 35% Cheaper, Time To Buy
  6. Marathon Petroleum Stock Capital Return Hits $59 Bil

Period Past Median Return
1M 10.5%
3M 2.8%
6M 44.2%
12M 58.1%

Historical Dip-Wise Details

HIMS had 11 events since 1/1/2020 where the dip threshold of -30% within 30 days was triggered

  • 103% median peak return within 1 year of dip event
  • 198 days is the median time to peak return after a dip event
  • -28% median max drawdown within 1 year of dip event

30 Day Dip HIMS Subsequent Performance
Date HIMS SPY 1Y Peak
Return
Max
Drop
# Days
to Peak
Median     58% 103% -28% 198
3272025 -31% -6% 58% 103% -21% 50
8072024 -31% -5% 215% 329% -15% 196
5032024 -33% -2% 365% 510% 0% 292
6202023 -31% 6% 168% 197% -31% 364
10192022 -37% -7% 47% 194% 0% 198
5102022 -33% -12% 205% 247% -10% 360
1282022 -32% -6% 92% 79% -28% 364
12032021 -30% -0% 14% 23% -47% 255
7132021 -31% 4% -46% 0% -69% 0
5132021 -38% 4% -61% 88% -62% 26
3192021 -35% 1% -65% 6% -73% 81

Hims & Hers Health Passes Basic Financial Quality Checks

Revenue growth, profitability, cash flow, and balance sheet strength need to be evaluated to reduce the risk of a dip being the sign of a deteriorating business situation.

Quality Metrics Value Quality Check
Revenue Growth (LTM) 86.0% Pass
Revenue Growth (3-Yr Avg) 77.9% Pass
Operating Cash Flow Margin (LTM) 18.7% Pass

Dip buying, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed the S&P, and clocked >91% returns since inception.